Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;48(2):117-21.
doi: 10.3164/jcbn.10-73. Epub 2011 Feb 26.

Mitochondrial Disorders in NSAIDs-induced Small Bowel Injury

Free PMC article

Mitochondrial Disorders in NSAIDs-induced Small Bowel Injury

Toshio Watanabe et al. J Clin Biochem Nutr. .
Free PMC article


Recent studies using small bowel endoscopy revealed that non-steroidal anti-inflammatory drugs including low-dose aspirin, can often induce small bowel injury. Non-steroidal anti-inflammatory drugs-induced small bowel mucosal injury involves various factors such as enterobacteria, cytokines, and bile. Experimental studies demonstrate that both mitochondrial disorders and inhibition of cyclooxygenases are required for development of non-steroidal anti-inflammatory drugs-induced small bowel injury. Mitochondrion is an organelle playing a central role in energy production in organisms. Many non-steroidal anti-inflammatory drugs directly cause mitochondrial disorders, which are attributable to uncoupling of oxidative phosphorylation induced by opening of the mega channel called mitochondrial permeability transition pore on the mitochondrial membrane by non-steroidal anti-inflammatory drugs. Bile acids and tumor necrosis factor-α also can open the permeability transition pore. The permeability transition pore opening induces the release of cytochrome c from mitochondrial matrix into the cytosol, which triggers a cascade of events that will lead to cell death. Therefore these mitochondrial disorders may cause disturbance of the mucosal barrier function and elevation of the small bowel permeability, and play particularly important roles in early processes of non-steroidal anti-inflammatory drugs-induced small bowel injury. Although no valid means of preventing or treating non-steroidal anti-inflammatory drugs-induced small bowel injury has been established, advances in mitochondrial studies may bring about innovation in the prevention and treatment of this kind of injury.

Keywords: aspirin; mitochondrial permeability transition; oxidative phosphorylation; uncoupling.


Fig. 1
Fig. 1
NSAIDs-induced small bowel injury. A, B: Capsule endoscope pictures (low-dose aspirin-induced small bowel injury). C, D: Double-balloon endoscope pictures (sulindac-induced small bowel ulcer). A: redness (arrow), B, C, D: ulcer.
Fig. 2
Fig. 2
Structure and function of mitochondrial permeability transition pore. HK, hexokinase; BR, benzodiazepine receptor; CK, creatinekinase; ANT, adenine nucleotide translocase; VDAC, voltage-dependent anion channel; CypD, cyclophilin D, OM, outer membrane; IM, inner membrane.

Similar articles

See all similar articles

Cited by 10 articles

See all "Cited by" articles


    1. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992;327:749–754. - PubMed
    1. Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature. 2000;405:417. - PubMed
    1. Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc. 2001;53:216–220. - PubMed
    1. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133–141. - PubMed
    1. Watanabe T, Sugimori S, Kameda N, et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol. 2008;6:1279–1282. - PubMed